D. Hecker et M. Lebwohl, TOPICAL CALCIPOTRIENE IN COMBINATION WITH UVB PHOTOTHERAPY FOR PSORIASIS, International journal of dermatology, 36(4), 1997, pp. 302-303
A total of 20 patients with symmetric plaque-type psoriasis were recru
ited for a controlled, investigator-blinded, right-left study. None of
the patients had used any therapy other than emollients for 2 months
prior to starting in the trial. All patients had a negative antinuclea
r antibody. By history, all patients had previously improved upon expo
sure to sunlight or ultraviolet light. Two symmetrical sites of equal
severity were selected as target areas. Each patient was treated on on
e side with mineral oil twice daily and on the opposite side with calc
ipotriene 0.005% ointment twice daily. The investigator was blinded as
to which site received which topical treatment. Both sides were treat
ed with equal doses of ultraviolet B (UVB) three times weekly in gradu
ated suberythemogenic doses. Ultraviolet B radiation was emitted by a
group of 6-ft fluorescent bulbs (Light Sources FS72 T12 UVB HO) in a s
tandard phototherapy unit.The above regimen was continued for a total
of 12 weeks. The severity of psoriasis in the target sites was rated b
y the examiner at baseline and at weekly intervals for the 12 weeks of
study. Target sites were rated by severity of erythema, scaling, plaq
ue elevation, and pruritus, with each of these parameters being assign
ed a score on a four-point scale: 0, clear; 1, mild; 2, moderate; 3, s
evere. The four scores were added together to arrive at a total severi
ty score for each of the target sites. Statistical analysis was perfor
med using the paired t test, P values less than 0.05 were considered s
tatistically significant. Eleven of the 20 patients (55%) showed a gre
ater decrease in the severity of their psoriasis with UVB plus calcipo
triene compared with UVB plus mineral oil. The difference in severity
scores between the two groups was statistically significant as early a
s week 1 (P < 0.05). The difference between the UVB and calcipotriene
group versus the UVB and mineral oil group peaked between weeks 3 and
6. The differences then decreased but remained statistically significa
nt through to week 12 (Fig. 1). There were no instances of local cutan
eous irritation, but mild photosensitivity occurred symmetrically on b
oth sides in three patients.